NEWS: Zyma seeking Savlon agency

Zyma Healthcare is hunting for a PR agency to work on its antiseptic brand Savlon.

Zyma Healthcare is hunting for a PR agency to work on its antiseptic

brand Savlon.



The company is understood to have shortlisted at least two agencies for

the business: Lowe Bell Good Relations and healthcare specialist Bates

Healthcom. Part of the Cordiant-owned advertising network Bates Dorland,

Bates Healthcom has handled Savlon’s pounds 2 million advertising

account since last October.



The brand, believed to represent in excess of pounds 50,000 in PR fees,

has been without an agency since the beginning of the year. Incumbent

Lynne Franks resigned the business after two years in order to take on

direct rival, Dettol - owned by one of its biggest clients, Reckitt and

Colman.



Last April Reckitt and Colman handed Lynne Franks PR almost all its

over-the-counter pharmaceutical brands including Lemsip, Disprin,

Fybogel and Bonjela - with a combined fee value of more than pounds

200,000. The agency was, however, unable to take on Dettol, until it had

completed its work on Savlon.



Lynne Franks also works on Zyma brands Piz Buin (sun care products) and

Nicotinell (nicotine patches) but both agency and client dismissed any

suggestion that these would be affected by the change on Savlon.



‘Zyma are an incredibly understanding client,’ said Lynne Franks

managing director Samantha Royston. ‘They are happy to continue to

retain us for any piece of business which is not going to be in conflict

with Reckitt and Colman.’



Savlon brand manager Julie Green said there had been ‘no damage to our

working relationship’ with Lynne Franks.



She added: ‘We’re going through some repackaging at the moment and we

wouldn’t be looking for a PR agency unless we had something to shout

about.’



Early last year Zyma launched the Savlon Baby range comprising nappy

cream, lotion, bath and surface spray to sit alongside its core

products. Further development of the brand seems likely.



The move comes at an uncertain time for Zyma. Its parent Ciba is

currently involved in what is, at pounds 42 billion, the biggest

corporate merger in history, linking up with fellow Swiss

pharmaceuticals giant Sandoz to form the world’s second-largest drugs

company.



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.